two new drugs for advanced breast cancer
October 1998
Roche is introducing two new drugs for advanced breast cancer...Xeloda (capecitabine) and Herceptin (trastuzumab).
Xeloda is a prodrug of 5-FU (5-fluorouracil).
It's taken ORALLY and metabolized to 5-FU in tumour cells.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive